166 related articles for article (PubMed ID: 3072590)
1. [Possibility of using interferon in the treatment of multiple myeloma].
Piatkowska-Jakubas B; Skotnicki AB; Blicharski J
Przegl Lek; 1988; 45(10):747-50. PubMed ID: 3072590
[No Abstract] [Full Text] [Related]
2. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486.
Oken MM; Leong T; Lenhard RE; Greipp PR; Kay NE; Van Ness B; Keimowitz RM; Kyle RA
Cancer; 1999 Sep; 86(6):957-68. PubMed ID: 10491521
[TBL] [Abstract][Full Text] [Related]
3. Combined alpha-2C-interferon/VMCP polychemotherapy versus VMCP polychemotherapy as induction therapy in multiple myeloma: a prospective randomized trial.
Scheithauer W; Cortelezzi A; Fritz E; Kührer I; Polli E; Baldini L; Ludwig H
J Biol Response Mod; 1989 Apr; 8(2):109-15. PubMed ID: 2659740
[TBL] [Abstract][Full Text] [Related]
4. [Interferon in the treatment of multiple myeloma].
Kuzmits R; Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Flener R; Scheithauer W
Acta Med Austriaca; 1985; 12(5):135-8. PubMed ID: 3914174
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of multiple myeloma in stages II and III with melphalan, prednisone, cyclophosphamide, vincristine and BCNU (M-2 protocol)].
Montalbán C; Sevilla F; Zapatero A; Blanco L; Sabán J; Serrano M; Serrano Ríos M
Rev Clin Esp; 1985 May; 176(8):392-5. PubMed ID: 3839590
[No Abstract] [Full Text] [Related]
6. [Treatment of multiple myeloma in stages I and II. Comparative study of an M-2 protocol and melphalan-prednisone].
Montalbán C; Zapatero A; Blanco L; Sevilla F; García Laraña J; Odriozola J
Sangre (Barc); 1984; 29(6):993-9. PubMed ID: 6549486
[No Abstract] [Full Text] [Related]
7. [Polychemotherapy versus melphalan-prednisone in multiple myeloma].
Leoni P; Salvi A; Brianzoni MF; Centurioni R; Montillo M; Olivieri A
G Clin Med; 1986 Dec; 67(5-6):291-6. PubMed ID: 3609590
[No Abstract] [Full Text] [Related]
8. [Chemotherapy of multiple myeloma].
Golenkov AK
Sov Med; 1991; (3):43-6. PubMed ID: 1882290
[No Abstract] [Full Text] [Related]
9. Interferon in multiple myeloma--does it pay?
Kedar I; Segal A
Isr J Med Sci; 1995 Oct; 31(10):635-7. PubMed ID: 7591691
[No Abstract] [Full Text] [Related]
10. Rate of M-component changes and clinical course of 23 responsive myeloma patients.
Riccardi A; Montecucco C; Merlini G; Cremonini N; Danova M; Ascari E
Haematologica; 1984; 69(3):305-14. PubMed ID: 6432642
[No Abstract] [Full Text] [Related]
11. Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
Snigurowicz J; Kraj M; Rostkowska J; Maj S; Mariańska B; Mendek E; Roszkowski S; Kilian Z; Kołakowski L
Arch Immunol Ther Exp (Warsz); 1981; 29(2):145-53. PubMed ID: 7030265
[No Abstract] [Full Text] [Related]
12. [Combination chemotherapy with vincristine, melphalan, CCNA, cyclophosphamide, prednisone in myeloma].
Le Loët X; Monconduit M; Menard JF; Deshayes P; Grobois B; Tanguy A; Prevost E; Piguet H
Rev Rhum Mal Osteoartic; 1984 May; 51(5):263-7. PubMed ID: 6740189
[TBL] [Abstract][Full Text] [Related]
13. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH
Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039
[TBL] [Abstract][Full Text] [Related]
14. [Preleukemia myelodysplastic syndrome after chemotherapy for multiple myeloma: "a new case"].
Raya Sánchez JM; González Brito G; Marsá Vila L; Brito Barroso ML; Hernández Nieto L
Sangre (Barc); 1991 Oct; 36(5):434-5. PubMed ID: 1816642
[No Abstract] [Full Text] [Related]
15. Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness.
Morstyn G; Schechter GP; Ihde DC; Carney DN; Eddy JL; Cohen MH; Minna JD; Bunn PA
Cancer Treat Rep; 1984 Dec; 68(12):1439-46. PubMed ID: 6391662
[TBL] [Abstract][Full Text] [Related]
16. [Combination chemotherapy with melphalan, cyclophosphamide, vincristine, ACNU and prednisolone (MEV(Ac)P) for multiple myeloma].
Takagi T; Oguro M; Sakai C
Rinsho Ketsueki; 1986 Dec; 27(12):2249-53. PubMed ID: 3471977
[No Abstract] [Full Text] [Related]
17. [Combined treatment, polychemotherapy and amino-hydroxybutylidene-diphosphonate, of a patient with multiple myeloma: remission and long survival].
Attardo-Parrinello G; Merlini G; Crema F; Fiorentini ML; Mazzone A; Cotti-Piccinelli E
Medicina (Firenze); 1988; 8(3):318-20. PubMed ID: 3231044
[No Abstract] [Full Text] [Related]
18. [Rheumatoid arthritis and multiple myeloma--the risk of a combination of the 2 diseases].
Lila AM; Mazurov VI; Novik AA
Ter Arkh; 1997; 69(2):50-2. PubMed ID: 9173578
[No Abstract] [Full Text] [Related]
19. Refractory multiple myeloma treated with homoharringtonine: report of two cases.
Yang X; Yang C; Shao K; Ye X; Meng H; Zhou Y; Qian W
Ann Hematol; 2007 Dec; 86(12):919-21. PubMed ID: 17641891
[No Abstract] [Full Text] [Related]
20. [Pneumonia caused by Salmonella in a patient with myeloma].
Fernández P; Roldán V; García MC; Gil MT; Rivas C
Sangre (Barc); 1995 Jun; 40(3):234-5. PubMed ID: 7570286
[No Abstract] [Full Text] [Related]
[Next] [New Search]
